INS and rheumatoid arthritis: In addition to the repeatedly reported reduction in muscle strength in RA patients [16–18], metabolic changes occur in both preclinical and later RA stages, including deterioration of blood lipid profile and insulin sensitivity [19–21] which may increase cardiovascular disease risk, summing up to a reduced life span [22].